Recherche
Enseignement
Solutions
S'identifier
FR
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Türkçe
JA - 日本語
PL - Polski
RU - Русский
HE - עִברִית
Department of Clinical Pharmacology
Jaeseong Oh has not added Biography.
If you are Jaeseong Oh and would like to personalize this page please email our Author Liaison for assistance.
A fixed-dose combination tablet of gemigliptin and metformin sustained release has comparable pharmacodynamic, pharmacokinetic, and tolerability profiles to separate tablets in healthy subjects.
Drug design, development and therapy , 2015 | Pubmed ID: 25678778
Pharmacokinetics of Second-Line Antituberculosis Drugs after Multiple Administrations in Healthy Volunteers.
Antimicrobial agents and chemotherapy Aug, 2015 | Pubmed ID: 25987620
Seoul National University Hospital
Seong Joon Ahn1,2,3,
Hye Kyoung Hong1,
Young Mi Na1,
Sang Jun Park1,2,
Jeeyun Ahn1,2,4,
Jaeseong Oh5,
Jae Yong Chung6,
Kyu Hyung Park1,2,
Se Joon Woo1,2
1Department of Ophthalmology, Seoul National University Bundang Hospital,
2Department of Ophthalmology, College of Medicine, Seoul National University,
3Department of Ophthalmology, Hanyang University Hospital,
4Department of Ophthalmology, Seoul Metropolitan Government-Seoul National University Boramae Medical Center,
5Department of Clinical Pharmacology, Seoul National University Hospital,
6Department of Clinical Pharmacology, Seoul National University Bundang Hospital
Confidentialité
Conditions d'utilisation
Politiques
Contactez-nous
RECOMMANDER À LA BIBLIOTHÈQUE
NEWSLETTERS JoVE
JoVE Journal
Collections de méthodes
JoVE Encyclopedia of Experiments
Archives
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Centre de ressources universitaires
Auteurs
Bibliothécaires
Accès
À PROPOS DE JoVE
Copyright © 2025 MyJoVE Corporation. Tous droits réservés.
Nous utilisons des cookies afin d'améliorer votre expérience sur notre site web.
En continuant à utiliser notre site ou en cliquant sur le bouton ''continuer'', vous acceptez l'utilisation de cookies.
Apprendre encore plus